We are live on ! Find out more
LIMNW

Liminatus Pharma Warrants
LIMNW

25 hedge funds and large institutions have $837K invested in Liminatus Pharma Warrants in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.33% more ownership

Funds ownership: 0% → 44.33% (+44%)

Holders
25
Holders Change
+25
Holders Change %
–
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
–
Reduced
–
Closed
–
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$172K
2
CS
Clear Street
New York
+$158K
3
AC
Aristeia Capital
Connecticut
+$61.6K
4
LA
Linden Advisors
New York
+$52.7K
5
SCM
Saba Capital Management
New York
+$45.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
1
Cantor Fitzgerald
New York
$210K +$172K +875,817 New
CS
2
Clear Street
New York
$193K +$158K +805,477 New
AC
3
Aristeia Capital
Connecticut
$67.3K +$61.6K +313,238 New
LA
4
Linden Advisors
New York
$56.3K +$52.7K +268,199 New
SCM
5
Saba Capital Management
New York
$56.1K +$45.9K +233,761 New
HCM
6
Highbridge Capital Management
New York
$32.5K – – –
MCM
7
Moore Capital Management
New York
$30.4K +$24.6K +125,000 New
MI
8
MMCAP International
Cayman Islands
$26.8K +$22K +111,745 New
PAMP
9
Polar Asset Management Partners
Ontario, Canada
$26.4K +$24.1K +122,688 New
WAM
10
Wolverine Asset Management
Illinois
$24.7K +$20.2K +102,987 New
AWG
11
Alpha Wave Global
New York
$21.6K +$17.5K +89,098 New
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$20.2K +$16.4K +83,353 New
BOCH
13
Blue Owl Capital Holdings
New York
$12K +$9.82K +50,000 New
PC
14
Periscope Capital
Ontario, Canada
$12K +$9.82K +50,000 New
Toronto Dominion Bank
15
Toronto Dominion Bank
Ontario, Canada
$8.44K +$6.92K +35,200 New
LP
16
LMR Partners
United Kingdom
$7.19K +$5.89K +29,961 New
ACA
17
Arena Capital Advisors
California
$7K +$5.73K +29,166 New
Jane Street
18
Jane Street
New York
$6.46K +$5.29K +26,943 New
LIA
19
Limestone Investment Advisors
New York
$5.41K +$4.43K +22,562 New
CSS
20
Cubist Systematic Strategies
Connecticut
$3.79K +$3.1K +15,778 New
MC
21
Meteora Capital
Florida
$3.6K +$2.95K +15,000 New
FTUS
22
Flow Traders U.S.
New York
$3K +$2.58K +13,110 New
DCM
23
Dupont Capital Management
Delaware
$1.52K +$1.23K +6,250 New
UBS Group
24
UBS Group
Switzerland
$485 +$397 +2,020 New
HIM
25
HGC Investment Management
Ontario, Canada
$300 +$246 +1,250 New
1
2

LIMNW Hedge Fund Activity: Q2 2025 in Review

25 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Liminatus Pharma Warrants (LIMNW) for Q2 2025, worth a combined $837K.

Buyers outnumbered sellers: 25 funds opened new LIMNW positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $172K.

  • 25 institutional investors held Liminatus Pharma Warrants (LIMNW) as of Q2 2025, up from 0 in Q1 2025.
  • Funds reported $837K of Liminatus Pharma Warrants stock for Q2 2025.
  • 25 funds opened new Liminatus Pharma Warrants positions in Q2 2025 and 0 closed out, a net change of +25 holders.
  • The largest Liminatus Pharma Warrants buyer in Q2 2025 was Cantor Fitzgerald, an estimated $172K added.

Based on aggregated 13F filings for Q2 2025.